Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Eli Lilly
Read More
Novo Nordisk Reduces Wegovy Prices in China Amid Rising Competition
Novo Nordisk has announced a reduction in the price of its blockbuster weight-loss drug Wegovy in China, as the Danish…
Carolyn Bertozzi rejoins Eli Lilly’s Board of Directors
Eli Lilly and Company has reappointed Nobel laureate Carolyn R. Bertozzi, Ph.D., to its Board of Directors, effective December 8,…
Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Eli Lilly Acquires Adverum Biotechnologies to Advance Gene Therapy for Vision Restoration
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Eli Lilly to Invest Over $1 Billion in India, Sets Up Manufacturing & Quality Hub in Hyderabad
Eli Lilly and Company has unveiled an ambitious plan to invest more than USD 1 billion in new contract manufacturing…
Eli Lilly Bets Big on India’s Weight-Loss Market, IMA Warns of Drug Misuse
US pharma giant Eli Lilly is preparing to expand its footprint in India’s fast-growing weight-loss drug market. After launching its…
The rising obesity epidemic in India
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Lilly and Apollo Hospitals Join Forces to Tackle Obesity and Diabetes in India
Eli Lilly and Company (India) has announced a strategic partnership with Apollo Health and Lifestyle and Apollo HealthCo both part…
Lupin Acquires Huminsulin from Eli Lilly to Strengthen Diabetes Care Portfolio in India
Global pharmaceutical company Lupin has announced the acquisition of the Huminsulin brand in India from Eli Lilly and Company. This…
- 1
- 2